Cancer-Related Pain
Cancer-related pain, which affects many cancer patients, can stem from the tumor itself, treatments, or diagnostic procedures, and may significantly impair quality of life. This pain is often chronic from the illness or acute from treatments, with medications prescribed based on its severity.
Health Outcomes
- Accelerated Recovery in Immunocompromised Mice
- Cancer-Related Supportive Effects
- Improved Cancer-Related Health Outcome
- Improved Clinical Outcomes
- Improved Natural Killer Cell Function
- Improved Overall Patient Outcomes
- Improved Pain Intensity
- Improved Pain Management
- Improved Pain Score
- Improved Recovery in Immunocompromised Individuals
- Improved Secondary Outcomes
- Improved Specific Elements Within Assessed Measures
- Increased Analgesic Capacity
- Increased Cellular Adhesion
- Increased Dose Tolerance
- Increased Narcotic Consumption
- Increased Need for Repeated Dosing
- Increased Pain
- Increased Pain-Free Days
- Increased Perceived Pain
- Increased Production of Bioactive Metabolites
- Modulated Nociceptive Signaling
- No Clinically Significant Safety or Tolerance Issues
- No Mutagenicity
- No Significant Change in Fatigue
- Normalized Expression of rhoB Gene
- Reduced Analgesic Use
- Reduced Apoptosis
- Reduced Average Pain
- Reduced Bodily Pain
- Reduced Interference Score
- Reduced Opioid Consumption
- Reduced Pain
- Reduced Pain Assessment Score
- Reduced Pain Frequency
- Reduced Pain Intensity
- Reduced Pain Scale
- Reduced Pain Score
- Reduced Pain Sensitivity
- Reduced Pain Severity
- Reduced Pain Symptom Score
- Reduced Pain Symptoms
- Reduced Pain-Related Disability
- Reduced Soreness
- Reduced Total Analgesic Dosage
- Reduced Worst Pain
- Supportive Effect in Breast Cancer Management